Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Josef Svejk who wrote (1257)	3/9/1998 12:59:00 AM
From: Merg	Respond to of 5736

Thanks for the post, I read them all and frankly feel my opinion is confirmed by these references. An initial blood sample is drawn on ALL newborns. Normal newborns are sent home within three days...Sick newborns require a longer stay and more extensive evaluation of all body functions, Bilirubin testing at that point must be more definitive (as in direct & indirect bilirubin levels) but it is easily performed on the samples drawn to do other more critical tests. The relative costs of a bili test indicated in these references is misleading because the figures shown are really the 'charge' to the patient/insurance co. and not an accurate assessment of what it actually costs the hospital lab to do this test. The first person article by the new mother is a compelling but highly emotional description of a mothers pain in witnessing a heel stick. But on the other hand it was evidently published by La Leche League-- (an organization founded upon the idea that you have to teach mothers how to breast feed {sic) My conclusion is that this is a limited use device because a bili test can be easily performed in a hospital setting at extremely small actual cost to the hospital. For a hospital to make a capital equipment purchase of this nature for something that performs only one test could never be comsidered cost effective. Perhaps as long as the hospital can charge the insurance company $25.00 to 30.00 per test (and the insurance company hasn't yet figured out this game it could be considered a revenue enhancing device.